advanced

Documents about advanced

• AIMS Cancer Outcomes Study#130988ClinicalTrials.gov
• Phase II FANG™ in Advanced Melanoma#152475ClinicalTrials.gov
• Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax#162462ClinicalTrials.gov
• ARID1A and/or KDM6A Mutation and CXCL13 Expression#252990ClinicalTrials.gov
• SW-682 in Advanced Solid Tumors#152393ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers#261495ClinicalTrials.gov
• Prospective Observation of Exercise Parameters in Advanced Heart Failure#162334ClinicalTrials.gov
• A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma#195310ClinicalTrials.gov
• Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial#140997ClinicalTrials.gov
• Plasmodium Immunotherapy for Advanced Malignant Solid Tumors#158209ClinicalTrials.gov
• Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer#160232ClinicalTrials.gov
• Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma#162452ClinicalTrials.gov
• Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma#208289ClinicalTrials.gov
• Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors#18705ClinicalTrials.gov
• A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)#261517ClinicalTrials.gov
• Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors#123412ClinicalTrials.gov
• Temsirolimus in Combination With Metformin in Patients With Advanced Cancers#143789ClinicalTrials.gov
• FS222 First in Human Study in Patients With Advanced Malignancies#217016ClinicalTrials.gov
• An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects#245574ClinicalTrials.gov
• Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma#256902ClinicalTrials.gov
• Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma#200217ClinicalTrials.gov
• Study of AMV564 in Subjects With Advanced Solid Tumors#208433ClinicalTrials.gov
• Plasmodium Immunotherapy for Breast and Liver Cancers#253014ClinicalTrials.gov
• Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery#154631ClinicalTrials.gov
• Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma#184850ClinicalTrials.gov
• Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.#28297ClinicalTrials.gov
• Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.#123458ClinicalTrials.gov
• A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors#148755ClinicalTrials.gov
• xmlschema patterns advanced#153242W3C TR
• Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC#67884ClinicalTrials.gov
• PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma#152421ClinicalTrials.gov
• Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy#160350ClinicalTrials.gov
• Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer#172310ClinicalTrials.gov
• Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer#184849ClinicalTrials.gov
• CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma#252993ClinicalTrials.gov
• Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer#261505ClinicalTrials.gov
• Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer#143549ClinicalTrials.gov
• Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma#148753ClinicalTrials.gov
• A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors#152479ClinicalTrials.gov
• Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC#158229ClinicalTrials.gov
• Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases.#180377ClinicalTrials.gov
• Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors#201777ClinicalTrials.gov
• Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer#217041ClinicalTrials.gov
• A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors#252999ClinicalTrials.gov
• Advanced Professional Video#132411IETF RFCs
• Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies#121374ClinicalTrials.gov
• Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer#152397ClinicalTrials.gov
• Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors#172299ClinicalTrials.gov
• Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma#180384ClinicalTrials.gov
• A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma#195399ClinicalTrials.gov

Related topics